Abstract
No public abstract is available from the verified source records.
Kajal Rahangdale, Rohit Mehtani, Bhaskar Nandi, Amit Kumar Dinda, Shantikumar V. Nair, Ashish Kumar Vyas
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
The liver as an immunological organ
10.1002/hep.21060 · 2006
Immune responses in the liver
10.1146/annurev-immunol-051116-052415 · 2018
Immunological tolerance – the liver effect
10.1034/j.1600-0528.2002.017419.x · 2000
The curious case of the 1960 Nobel prize to Burnet and Medawar
10.1111/imm.12558 · 2016
Control of regulatory T cell development by the transcription factor Foxp3
10.1126/science.1079490 · 2003
Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease
10.1084/jem.161.1.72 · 1985
T follicular regulatory cells: choreographers of productive germinal center responses
10.3389/fimmu.2021.679909 · 2021
A distinct subpopulation of CD25- T-follicular regulatory cells localizes in the germinal centers
10.1073/pnas.1705551114 · 2017
Foxp3+ follicular regulatory T cells control T follicular helper cells and the germinal center response
10.1038/nm.2425 · 2011
datacite
Confidence 0%
Follicular helper T cells
10.1146/annurev-immunol-041015-055605 · 2016
The role of regulatory T cells and follicular T helper cells in HBV infection
10.3389/fimmu.2023.1169601 · 2023
The function of T follicular helper cells in the autoimmune liver diseases
10.1155/2020/5679254 · 2020
CTLA-4 interferes with the HBV-specific T cell immune response (review)
2018
Toll like receptor 4 and hepatocellular carcinoma; a systematic review
10.1016/j.lfs.2017.04.025 · 2017
The multiple molecular paths of antibody suppression by TFR cells
10.1111/ajt.14178 · 2017
Current advances in follicular regulatory T-cell biology
10.1615/critrevimmunol.2022045746 · 2022
Follicular regulatory T (Tfr) cells with dual Foxp3 and Bcl6 expression suppress germinal center reactions
10.1038/nm.2426 · 2011
Regulation of the germinal center reaction by Foxp3+ follicular regulatory T cells
10.4049/jimmunol.1101328 · 2011
T follicular regulatory cells and IL-10 promote food antigen–specific IgE
10.1172/jci132249 · 2020
Follicular regulatory T cells can be specific for the immunizing antigen and derive from naive T cells
10.1038/ncomms10579 · 2016
Regulatory T cells: mechanisms of suppression and impairment in autoimmune liver disease
10.1002/iub.1349 · 2015
PD-1 suppresses human CD38+ circulating Tfr cells and regulates humoral immunity
10.1136/jitc-2024-010026 · 2025
The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood
10.1038/ni.2496 · 2013
Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4
10.1016/1074-7613(95)90125-6 · 1995
The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory and T regulatory cells
10.1016/j.immuni.2014.12.005 · 2014
Spatial distribution and function of T follicular regulatory cells in human lymph nodes
10.1084/jem.20171940 · 2018
CTLA-4 regulates T follicular regulatory cell differentiation and participates in intestinal damage caused by spontaneous autoimmunity
10.1016/j.bbrc.2018.09.182 · 2018
CTLA-4 controls follicular helper T-cell differentiation by regulating the strength of CD28 engagement
10.1073/pnas.1414576112 · 2015
PD-1 controls follicular T helper cell positioning and function
10.1016/j.immuni.2018.06.012 · 2018
Unresolved referenced work
Kept as external metadata until matched
Hypoxia-adenosinergic regulation of B cell responses
10.3389/fimmu.2024.1478506 · 2024
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
10.1084/jem.20062512 · 2007
Control of the germinal center by follicular regulatory T cells during infection
10.3389/fimmu.2018.02704 · 2018
Suppression by TFR cells leads to durable and selective inhibition of B cell effector function
10.1038/ni.3578 · 2016
Are follicular regulatory T cells involved in autoimmune diseases?
10.3389/fimmu.2017.01790 · 2017
Suppressive might of a few: T follicular regulatory cells impede auto-reactivity despite being outnumbered in the germinal centres
10.3389/fimmu.2023.1253704 · 2023
Altered follicular regulatory T (Tfr)- and helper T (Tfh)-cell subsets are associated with autoantibody levels in microscopic polyangiitis patients
10.1002/eji.202049093 · 2021
Dysregulated TFR and TFH cells correlate with B-cell differentiation and antibody production in autoimmune hepatitis
10.1111/jcmm.14997 · 2020
TCF1 and LEF1 control Treg competitive survival and Tfr development to prevent autoimmune diseases
10.1016/j.celrep.2019.05.061 · 2019
Regulatory T cell induction strategies and applications in the treatment of immune and non-immune diseases
10.1038/s41392-026-02910-2 · 2026
Tfr-Tfh index: a new predicator for recurrence of hepatocellular carcinoma patients with HBV infection after curative resection
10.1016/j.cca.2020.10.017 · doi-reference
Bioinformatic-based mechanism identification of E2F1-related ceRNA and E2F1 immunoassays in hepatocellular carcinoma
10.21037/jgo-22-674 · doi-reference
CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis
10.1002/hep.27306 · doi-reference
Circulating follicular helper T cells presented distinctively different responses toward bacterial antigens in primary biliary cholangitis
10.1016/j.intimp.2017.08.004 · doi-reference
Profiling of circulating T follicular helper and T peripheral helper cell subsets in patients with primary biliary cholangitis
10.1016/j.imlet.2025.107100 · doi-reference
The interplay of type I and type II interferons in murine autoimmune cholangitis as a basis for sex-biased autoimmunity
10.1002/hep.29524 · doi-reference
Treatment with a JAK1/2 inhibitor ameliorates murine autoimmune cholangitis induced by IFN overexpression
10.1038/s41423-022-00904-y · doi-reference
Dysregulation of circulating Tfr/Tfh ratio in primary biliary cholangitis
10.1111/sji.12616 · doi-reference
Comprehensive analysis of immune signatures in primary biliary cholangitis and autoimmune hepatitis
10.1093/jleuko/qiae085 · doi-reference
HCV-associated exosomes promote myeloid-derived suppressor cell expansion via inhibiting miR-124 to regulate T follicular cell differentiation and function
10.1038/s41421-018-0052-z · doi-reference
HBV coinfection with HCV alters circulating Tfh cell distribution and impairs HCV neutralizing antibody responses
10.1111/jvh.13106 · doi-reference
Induction of peripheral blood T follicular helper cells expressing ICOS correlates with antibody response to hepatitis B vaccination
10.1002/jmv.25585 · doi-reference
Immune-mediated drug-induced liver injury: immunogenetics and experimental models
10.3390/ijms22094557 · doi-reference
Selection for liver transplantation
10.1002/cld.218 · doi-reference
The gut–liver axis in drug-induced liver injury (DILI): interplay between gut microbiota, intestinal barrier, and immune system
10.1016/j.apsb.2026.04.014 · doi-reference
Introduction to the special issue: the Immunopeptidome
10.1016/j.smim.2023.101798 · doi-reference
Chemokine (C-X-C motif) ligand 13 promotes intrahepatic chemokine (C-X-C motif) receptor 5+ lymphocyte homing and aberrant B-cell immune responses in primary biliary cirrhosis
10.1002/hep.27725 · doi-reference
Follicular T helper cell signatures in primary biliary cholangitis and primary Sclerosing cholangitis
10.1002/hep4.1226 · doi-reference
Current understanding of primary biliary cholangitis
10.3350/cmh.2020.0028 · doi-reference
Increased numbers of circulating ICOS+ follicular helper T and CD38+ plasma cells in patients with newly diagnosed primary biliary cirrhosis
10.1007/s10620-014-3372-3 · doi-reference
Autoantibodies in the follow-up of autoimmune hepatitis
10.1016/j.jtauto.2026.100369 · doi-reference
Immune cells in alcohol-related liver disease
10.1016/j.livres.2022.01.001 · doi-reference
Levels of circulating follicular helper T cells, T helper 1 cells, and the prognostic significance of soluble form of CD40 ligand on survival in patients with alcoholic cirrhosis
10.1016/j.livres.2018.02.001 · doi-reference
Alcohol-associated liver disease
10.1172/jci176345 · doi-reference
Alcohol-associated liver disease-global epidemiology
10.1097/hep.0000000000000899 · doi-reference
Interaction between Galectin-9/TIM-3 pathway and follicular helper CD4+ T cells contributes to viral persistence in chronic hepatitis C
10.1016/j.biopha.2017.07.134 · doi-reference
Circulating T follicular helper cells are associated with rapid virological response in chronic hepatitis C patients undergoing peginterferon therapy
10.1016/j.intimp.2016.03.005 · doi-reference
Circulating regulatory Tfh cells are enriched in patients with chronic hepatitis B infection and induce the differentiation of regulatory B cells
10.1016/j.yexcr.2018.02.031 · doi-reference
Immune response and treatment targets of chronic hepatitis B virus infection: innate and adaptive immunity
10.3389/fcimb.2023.1206720 · doi-reference
IL-27 supports germinal center function by enhancing IL-21 production and the function of T follicular helper cells
10.1084/jem.20100064 · doi-reference
Increased circulating T follicular helper cells induced via IL-12/21 in patients with acute on chronic Hepatitis B liver failure
10.3389/fimmu.2021.641362 · doi-reference
CXCR5+ CD4+ T cell subsets and their relationship to immune dysfunction in chronic hepatitis B-associated liver cirrhosis
10.1111/jgh.14866 · doi-reference
Immune-mediated liver injury in Hepatitis B virus infection
10.4110/in.2015.15.4.191 · doi-reference
Hepatitis B virus as a risk factor for hepatocellular carcinoma: there is still much work to do
10.1016/j.livres.2024.05.004 · doi-reference
Virus coinfection and superinfection
10.1101/cshperspect.a021550 · doi-reference
Viral Hepatitis B: clinical and epidemiological characteristics
10.1101/cshperspect.a024935 · doi-reference
Vertical transmission of hepatitis B virus in the WHO African region: a systematic review and meta-analysis
10.1016/s2214-109x(24)00506-0 · doi-reference
From hepatitis a to E: a critical review of viral hepatitis
10.3748/wjg.v27.i16.1691 · doi-reference
Comprehensive analysis of NAFLD and the therapeutic target identified
10.3389/fcell.2021.704704 · doi-reference
Metabolic control of TFH cells and humoral immunity by phosphatidylethanolamine
10.1038/s41586-021-03692-z · doi-reference